Literature DB >> 32059700

Short and long-term barriers and facilitators of skin self-examination among individuals diagnosed with melanoma.

Adina Coroiu1,2, Chelsea Moran3, Catherine Bergeron2, Martin Drapeau2,4, Beatrice Wang5, Abbas Kezouh6, Jochen Ernst7, Gerald Batist8,9,10,11,12, Annett Körner2,10,13,14,15.   

Abstract

BACKGROUND: Melanoma can be lethal if not detected early and treated. Early detection can be facilitated via skin self-examination (SSE) and as such, SSE is part of melanoma follow-up care for individuals with a prior history, who face a life-long risk of reoccurrence. The objective of the current study was to identify short- and long-term predictors of SSE among melanoma survivors to inform future prevention interventions in high-risk groups.
METHOD: This is an observational study with longitudinal assessments conducted with adult melanoma patients in active follow-up care. PRIMARY OUTCOME MEASURES: Behavioral outcomes, comprehensive SSE (checking up to 5 body areas in the last 3 months) and optimal SSE (checking the entire body at least monthly in the last 3 months) were assessed at 3, 12, and 24 months post a dermatological educational session on skin cancer prevention. T tests and chi square analyses were used to examine changes in outcomes from 3 to 12 and 24 months. Linear and logistic regression models were used to examine the association between predictors and the primary outcomes.
RESULTS: Comprehensive SSE did not decrease significantly from 3 (M = 2.7, SD = 1.1) to 12 (M = 2.6, SD = 1.2) and 24 months (M = 2.4, SD = 1.2) post the education session, with the stronger predictor at all timepoints being intentions to perform SSE. Optimal SSE was higher at 3 months (59%) compared to 12 (46%) and 24 months (34%), with key predictors including self-efficacy and intentions to perform SSE and male sex at 3 months post; self-efficacy and reliance on medical advice at 12 months; and (lower) education and self-efficacy at 24 months.
CONCLUSIONS: The key findings of this study are that 1) survivors maintain SSE behaviour over time, but rates of SSE performed in agreement with medical recommendations are higher immediately post standard dermatological education (i.e. usual care) and decrease somewhat over a 24-month period; and 2) the strongest psycho-social predictors of SSE are intentions and self-efficacy to perform the behavior, which are highly modifiable, for example via motivational interviewing and goal setting health interventions.

Entities:  

Keywords:  Melanoma early detection; Melanoma patients; Observational study; Skin self-examination

Year:  2020        PMID: 32059700     DOI: 10.1186/s12885-019-6476-5

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  4 in total

1.  Moderators of the Effects of mySmartSkin, a Web-Based Intervention to Promote Skin Self-examination and Sun Protection Among Individuals Diagnosed With Melanoma.

Authors:  Sharon Manne; Carolyn J Heckman; Deborah Kashy; Lee Ritterband; Frances Thorndike; Carolina Lozada; Elliot J Coups
Journal:  Ann Behav Med       Date:  2022-08-02

2.  Melanoma detection by skin self-examination targeting at-risk women: A randomized controlled trial with telemedicine support for concerning moles.

Authors:  June K Robinson; Samer Wahood; Sophia Ly; Jessie Kirk; Jamie Yoon; James Sterritt; Elizabeth Gray; Mary Kwasny
Journal:  Prev Med Rep       Date:  2021-08-26

3.  Describing, predicting and explaining adherence to total skin self-examination (TSSE) in people with melanoma: a 12-month longitudinal study.

Authors:  Julia L Allan; Derek W Johnston; Marie Johnston; Peter Murchie
Journal:  BMJ Open       Date:  2022-08-30       Impact factor: 3.006

4.  The Achieving Self-directed Integrated Cancer Aftercare Intervention for Detection of Recurrent and Second Primary Melanoma in Survivors of Melanoma: Pilot Randomized Controlled Trial.

Authors:  Peter Murchie; Lynda Constable; Susan Hall; William Brant; Julia Allan; Marie Johnston; Judith Masthoff; Amanda Lee; Shaun Treweek; Dolapo Ayansina; Charlotte Proby; Kaz Rahman; Fiona Walter; Nigel Burrows; Amer Durrani; Graeme Maclennan
Journal:  JMIR Cancer       Date:  2022-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.